Farmacopea Indú

The latest Edition of Indian Pharmacopoeia, IP-2018 has been released on 29th September, 2017 by Sh. C.K. Mishra, Secretary Health & Family Welfare, Govt. of India in the presence of senior officers of Ministry of Health & Family Welfare and the IP Commission. The IP is an authoritative and legally enforceable book of standard of drugs manufactured/marketed in India. It is published by the Indian Pharmacopoeia Commission (IPC) on behalf of the Ministry of Health & Family Welfare, Government of India in fulfillment of the requirements of the Drugs and Cosmetics Act, 1940 and the Rules there under. It intends to help in the licensing of manufacturing, inspection and distribution of medicines. Publication of IP on regular basis is an important mandate of IPC aimed at improvement of health of the people through ensuring the quality, safety and efficacy of medicines. The Commission has been receiving significant advisory and directions from regulatory and valuable inputs from industrial houses, academic institutions, national laboratories, individual scientists and others. IP-2018 has been brought out in 4 Volumes incorporating 220 new monographs (Chemical Monographs (170), Herbal Monographs (15), Blood and Blood related products (10), Vaccines and Immunosera for Human use monographs (02), Radiopharmaceutical monographs (03), Biotechnology Derived Therapeutic Products (06), Veterinary monographs (14)), 366 revised monographs and 7 omissions. Salient Features of IP-2018 Keeping in view the essential requirement for harmonization of analytical methods with those accepted internationally, steps have been taken for monitoring drug standards. General Chemical tests & Thin Layer Chromatography (TLC) for identification of an article have been almost eliminated and more specific infrared, ultraviolet spectrophotometer and HPLC tests have been given emphasis. The concept of relying on published infrared spectra as a basis for identification has been continued. The use of chromatographic methods has been greatly extended to cope with the need for more specificity in assays and in particular, in assessing the nature and extent of impurities in ingredients and products. Most of the existing Assays and Related Substances Test methods are upgraded by liquid chromatographic in view to harmonize with other International Pharmacopoeia. Page 2 of 7 Pyrogen test have been replaced by Bacterial Endotoxin test (BET) in parenteral preparations and other monographs. For ease of access to make Pharmacopoeia more user friendly, Index has been incorporated in Volume-I along with that already existing in Volume-IV of IP. 53 New Fixed Dose Combination (FDC’s) combination monographs have been included, out of which 25 FDC monographs are not available in any Pharmacopoeia. General Chapters on Volumetric Glassware, Conductivity, Dissolution test, Disintegration test, Dimensions of Hard Gelatin Capsule Shells etc. have been revised. For Controlling the Microbial quality of all the medicinal product general chapter on Maintenance, Identification, Preservation and Disposal of Microorganism have been revised.